D I S S E C T I N G B U S I N E S S
Diane Onken , Head of Sales at Americas at Envirotainer , dives into the considerations to be made during the patent life cycle in the pharma industry .
MANAGING PATENT CLIFFS IN THE PHARMACEUTICAL INDUSTRY
For pharmaceutical manufacturers , patents are vital stepping stones that allow companies to recover large investments and fuel future research and breakthroughs . They motivate manufacturers to invest in the development of innovative and effective treatments that can significantly improve patient health outcomes .
But as the products approach the end of patent protection , manufacturers face a challenge known as the patent cliff . This period can reduce the profitability of drugs as the market opens up to other companies focusing on manufacturing generic drugs , driving down the price . However , it also makes life-saving medications accessible to a wider population , particularly in low-income countries who rely on medicines that are off patent or ‘ generic ’. This balance is crucial .
www . intelligenthealth . tech 29